← ANALYSTS · TIPRANKS
Ryan Deschner · Raymond James
Hits
69%
40 of 58 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+41.7%
Over a year after the rating, TipRanks’ measure
Our companies rated now
12
Buy / hold / sell: 12 / 0 / 0
Upside of the analyst’s targets
+220.2%
Average over 7 current targets, to the last price
The market’s answer to the ratings
+8.7%
Day-0 move against SPY in the rating’s direction, average over 7 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 16on TipRanks 09:12 | PVLAIWMPalvella Therapeutics · $1.8B | Reiterated | Buy | — | — | −4.4% | ↗ |
| Sep 30on TipRanks 14:15 | LQDAIWMLiquidia Technologies · $3.1B | Reiterated | Buy | $106 → $53.00−50.0% | +54.3% | −57.0%next day −7.7% · 5 days −13.7% | ↗ |
| Sep 15on TipRanks 10:15 | VERAIWMVera Therapeutics · $2.1B | Reiterated | Buy | — | — | −0.7%next day −5.2% · 5 days +5.3% | ↗ |
| Aug 7on TipRanks 09:40 | TRVIIWMTrevi Therapeutics · $1.7B | Reiterated | Buy | $40.00 | +236.7% | −0.6%next day −3.8% · 5 days −0.7% | ↗ |
| Jun 26on TipRanks Jun 29 02:25 | PRQRProQR · $228M | Reiterated | Buy | $14.00 → $10.00−28.6% | +663.4% | −1.5%next day +18.0% · 5 days +9.4% | ↗ |
| Jun 26on TipRanks 08:20 | ACHVIWMAchieve Life Sciences · $717M | Initiated | Buy | $20.00 | +213.5% | +6.3%next day +1.8% · 5 days +4.1% | ↗ |
| Jun 24on TipRanks 11:05 | VKTXViking Therapeutics · $3.4B | Reiterated | Buy | — | — | +8.8%next day −2.5% · 5 days −2.7% | ↗ |
| Jun 12on TipRanks 15:05 | DNTHIWMDianthus Therapeutics · $4.2B | Reiterated | Buy | — | — | +6.8%next day −1.2% · 5 days +5.8% | ↗ |
| Jun 10on TipRanks 07:36 | ADMAIWMADMA Biologics · $2.4B | Initiated | Buy | $21.00 | +96.6% | +6.0%next day −3.6% · 5 days −2.8% | ↗ |
| May 7on TipRanks 08:50 | MIRMIWMMirum Pharmaceuticals · $5.3B | Reiterated | Buy | $164 → $165+0.6% | +105.9% | −6.2%next day +3.3% · 5 days +6.0% | ↗ |
| Mar 13on TipRanks 05:45 | KRROIWMKorro Bio · $137M | Upgrade | Buy | $23.00 | +170.9% | +11.9%next day −2.6% · 5 days −14.2% | ↗ |
| Jan 9on TipRanks 09:45 | SPRYIWMARS Pharmaceuticals · $405M | Reiterated | Buy | — | — | +18.6%next day −13.0% · 5 days −18.3% | ↗ |
| Nov 19on TipRanks 06:50 | PVLAIWMPalvella Therapeutics · $1.8B | Upgrade | Buy | $92.00 → $143+55.4% | +18.9% | +16.5%next day −4.0% · 5 days +0.6% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗